ADHC Big News READ! American Diversified Holdin
Post# of 103030
(Total Views: 514)
Posted On: 05/08/2018 9:26:11 AM
ADHC Big News READ!
American Diversified Holdings Corporation Issues Updates On Brazos Biomedical, LLC Acquisition
9:00 am ET May 8, 2018 (PR Newswire) Print
American Diversified Holdings Corporation announced today that it has met with the management team of Brazos Biomedical llc and has received all relevant due diligence information required to complete acquisition. ADHC is in the process of reviewing relevant documentation involving the AURACIStm TENS Migraine therapy system including all the patent filings, patent license agreement, technical engineering schematics, trademark filings, FDA plans, patient study information and other related documents.
The terms and conditions of the Brazos Biomedical llc acquisition (BRAZOS), were not disclosed pending completion of standard due diligence.
In additional news ADHC management has met with its Securities counsel to discuss the requirements for filing of the form 10 and subsequent application to begin trading on the OTC QB. Management has also met with its PCAOB (Public Company Accounting Oversight Board) SEC approved auditing firm and has received an engagement letter to initiate the auditing process.
"Our team is moving rapidly along the path to closing the Brazos Biomedical llc acquisition," commented ADHC. "All parties are in substantial agreement with the terms and conditions and we look forward to building a great company together."
ADHC will keep shareholders informed as events progress.
ADHC is a holding company that provides executive management, corporate governance, administrative support, financial advice, and introductions to capital sources to various micro-cap private and public companies that have proven revenues and business models.
BRAZOS BIOMEDICAL LLC is a bio device company utilizing electrostimulation for pain management to improve patient outcomes through creative innovation with a core competency in the migraine and headache pain space.
For more information: www.brazosbio.com
This press release contains forward-looking statements pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements include risks and uncertainties that may cause the Company's plans to change and are in no way intended to guarantee that the Company will be successful in executing its plans. common stock currently trades on the over-the-counter under the symbol ADHC. This press release in no way constitutes any recommendation regarding the securities of ADHC or its affiliates. Any person reading this press release is advised that this release should be considered in the light of all facts and circumstances regarding the business and financial condition and prospects of ADHC, and no reference has been made that this release contains all information.
American Diversified Holdings Corporation Issues Updates On Brazos Biomedical, LLC Acquisition
9:00 am ET May 8, 2018 (PR Newswire) Print
American Diversified Holdings Corporation announced today that it has met with the management team of Brazos Biomedical llc and has received all relevant due diligence information required to complete acquisition. ADHC is in the process of reviewing relevant documentation involving the AURACIStm TENS Migraine therapy system including all the patent filings, patent license agreement, technical engineering schematics, trademark filings, FDA plans, patient study information and other related documents.
The terms and conditions of the Brazos Biomedical llc acquisition (BRAZOS), were not disclosed pending completion of standard due diligence.
In additional news ADHC management has met with its Securities counsel to discuss the requirements for filing of the form 10 and subsequent application to begin trading on the OTC QB. Management has also met with its PCAOB (Public Company Accounting Oversight Board) SEC approved auditing firm and has received an engagement letter to initiate the auditing process.
"Our team is moving rapidly along the path to closing the Brazos Biomedical llc acquisition," commented ADHC. "All parties are in substantial agreement with the terms and conditions and we look forward to building a great company together."
ADHC will keep shareholders informed as events progress.
ADHC is a holding company that provides executive management, corporate governance, administrative support, financial advice, and introductions to capital sources to various micro-cap private and public companies that have proven revenues and business models.
BRAZOS BIOMEDICAL LLC is a bio device company utilizing electrostimulation for pain management to improve patient outcomes through creative innovation with a core competency in the migraine and headache pain space.
For more information: www.brazosbio.com
This press release contains forward-looking statements pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements include risks and uncertainties that may cause the Company's plans to change and are in no way intended to guarantee that the Company will be successful in executing its plans. common stock currently trades on the over-the-counter under the symbol ADHC. This press release in no way constitutes any recommendation regarding the securities of ADHC or its affiliates. Any person reading this press release is advised that this release should be considered in the light of all facts and circumstances regarding the business and financial condition and prospects of ADHC, and no reference has been made that this release contains all information.
(0)
(0)Scroll down for more posts ▼